Abstract
In the preceding discussion of required characteristics of controls, reference was made to the types of materials (including archival tissues) that are available today and may be adapted to fill the range of necessary IHC controls. Reference also was made to the AIMM Control Series of papers that represent the most complete published survey of how to establish optimal control systems. The current text is focused upon principles and limitations that may affect outcome of biomarker testing; for practical recommendations on how to establish optimal control systems the original AIMM control series should be consulted. These papers are listed in Table 10.1 for convenience; their content underlies much of the basis of this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Investig. 1986;55:244–8.
Bevilacqua G, Bosman FT, Dassesse T, Höfler H. The role of the pathologist in tissue banking: European consensus expert group report. Virchows Arch. 2010;456:449–54. https://doi.org/10.1007/s00428-010-0887-7.
Canadian Biomarker Quality Assurance—Programme canadien d’assurance de la qualité des biomarqueurs. https://www.cbqa.ca/
Cartun R, Taylor CR. Techniques of immunohistochemistry: principles, pitfalls and standardization. In: Dabbs DJ, editor. Comprehensive diagnostic immunohistochemistry. 5th ed. Amsterdam: Elsevier; 2018.
Cheung CC, D’Arrigo C, Dietel M, et al. Evolution of quality assurance of clinical immunohistochemistry in the era of precision medicine—part 1: fit-for-purpose approach to classification of clinical immunohistochemistry tests. From the international society for immunohistochemistry and molecular morphology (ISIMM) and international quality network for pathology (IQN path). Appl Immunohistochem Mol Morph. 2017a;25:4–11.
Cheung CC, D’Arrigo C, Dietel M, et al. Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine—part 4: tissue tools for quality assurance in immunohistochemistry. From the international society for immunohistochemistry and molecular morphology (ISIMM) and international quality network for pathology (IQN path). Appl Immunohistochem Mol Morph. 2017b;25:227–30.
College of American Pathologists Accreditation Checklists. 2020. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwizm5r1x4XvAhXRIDQIHQcLBDYQFjABegQIAhAD&url=https%3A%2F%2Fdocuments.cap.org%2Fdocuments%2Fcap-accreditation-checklists.pdf&usg=AOvVaw2x4EVwmVwK98oVt8QiUyZG
Hewitt SM, Robinowitz M, Bogen SA, Gown AM, Kalra KL, Otis CN, Spaulding B, Taylor CR. Quality assurance for design control and implementation of immunohistochemistry assays: approved guidelines, vol. 31. 2nd ed. Wayne, PA: Clinical Lab Standards Institute; 2011. p. 4.
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844–7.
McDonald SA. Principles of research tissue banking and specimen evaluation from the pathologist’s perspective. Biopreserv Biobank. 2010;8:197–201.
National Cancer Institute Best Practices for Biospecimens. Resources. 2007. http://biospecimens.cancer.gov/global/pdfs/NCI_Best_Practices_060507.pdf
National Cancer Institute Best Practices for Biospecimens. Report of the NCI-NIST biospecimen quality assessment & standards development workshop (Washington DC). 2011. https://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf. Accessed 20–22 Oct 2010.
Nielsen S. External quality assessment for immunohistochemistry: experiences from NordiQC. Biotech Histochem. 2015;90:1–10. https://doi.org/10.3109/10520295.2015.1033462.
NordiQC. https://www.nordiqc.org/
Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and over expression in bladder cancer. Am J Pathol. 2000;157:787–94.
Sheppard E, Madej RM, Alfaro MP, et al. Collection, transport, preparation, and storage of specimens for molecular methods. 2nd ed. Wayne, PA: Clinical Lab Standards Institute; 2020. MM13
Skacel M, Skilton B, Pettay JD, Tubbs RR. Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens. Appl Immunohistochem Mol Morph. 2002;10:1–6.
Taylor CR. Focus on biospecimens: the issue is the tissue. Observations on the “NCI-NIST fitness for purpose quality assessment and standards workshop”. October 2010. Appl Immunohistochem Mol Morph. 2011;19:95–8.
Taylor CR, Burns J. The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody. J Clin Pathol. 1974;27:14–20.
Taylor CR, Cote RJ, editors. Immunomicroscopy: a diagnostic tool for the surgical pathologist. 3rd ed. Saunders, PA: Elsevier; 2005. (1st edition, Taylor was 1986; 2nd edition, Taylor and Cote was 1994)
Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu E, Swanson P, Taylor CR, Vyberg M. Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc committee. Appl Immunohistochem Mol Morph. 2014;22:241–52.
Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu E, Swanson P, Taylor CR, Vyberg M. Standardization of positive controls and introduction of immunohistochemistry critical assay performance controls (iCAPCs) in diagnostic immunohistochemistry: recommendations from the international ad hoc committee. Appl Immunohistochem Mol Morph. 2015;23:1–18.
Torlakovic EE, Cheung CC, D’Arrigo C, et al. Evolution of quality assurance of clinical immunohistochemistry in the era of precision medicine—part 2: immunohistochemistry test performance characteristics. From the international society for immunohistochemistry and molecular morphology (ISIMM) and international quality network for pathology (IQN path). Appl Immunohistochem Mol Morph. 2017a;25:79–85.
Torlakovic EE, Cheung CC, D’Arrigo C, et al. Evolution of quality assurance for clinical immunohistochemistry in the era of precision medicine—part 3: technical validation of immunohistochemistry (IHC) assays in clinical IHC Laboratories. From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and international quality network for pathology (IQN path). Appl Immunohistochem Mol Morph. 2017b;25:151–9.
UKNEQAS. Immunocytochemistry and in situ hybridization. https://ukneqasiccish.org/
Wang J, Taylor CR. Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma: application of tissue microarray technique. Appl Immunohistochem Mol Morph. 2003;11:206–13.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jasani, B., Huss, R., Taylor, C.R. (2021). Analytical Phase: Current Controls; Fit for Purpose Selection and Validation. In: Precision Cancer Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-84087-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-84087-7_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84086-0
Online ISBN: 978-3-030-84087-7
eBook Packages: MedicineMedicine (R0)